Effect of a new drug, N-(2-endobicyclo-(2,2,1)-heptane)-diethylaminoacetamide hydrochloride (ERL-239), on mean arterial blood pressure, cardiac output, coronary blood flow, cardiac oxygen consumption, work and efficiency.

The Journal of pharmacology and experimental therapeutics ·Vol. 126 ·No. 2 ·1959-06-00 ·Pages 164-7

WEGRIA R, NAKANO J, McGIFF JC, MURAVIEV T, ZEKERT H, BLUMENTHAL MR

Abstract

暂无摘要

Keywords

BLOOD PRESSURE/effect of drugs on CORONARY VESSELS/effect of drugs on HEART/effect of drugs on MYOCARDIUM/metabolism VASOMOTOR DRUGS/effects

MeSH Terms

Blood Pressure/drug effects Cardiac Output Coronary Vessels/drug effects Heart/drug effects Hemodynamics Heptanes Humans Myocardium/metabolism Oxygen Consumption Vasoconstrictor Agents Vasodilator Agents/pharmacology

Chemicals

Heptanes Vasoconstrictor Agents Vasodilator Agents

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

WEGRIA R

NAKANO J

McGIFF J C

MURAVIEV T

ZEKERT H

BLUMENTHAL M R

Article Info

Journal

The Journal of pharmacology and experimental therapeutics

Abbr.

J Pharmacol Exp Ther

ISSN

0022-3565

Published

1959-06-00

Pages

164-7

Language

English

Region

United States

NLM ID

0376362

Subset

External Links

PubMed source View journal details

Analysis Services

Effect of a new drug, N-(2-endobicyclo-(2,2,1)-heptane)-diethylaminoacetamide hydrochloride (ERL-239), on mean arterial blood pressure, cardiac output, coronary blood flow, cardiac oxygen consumption, work and efficiency.

Contact

WeChat Official Account